AbstractBetween July 2003 and March 2004, nine patients with pretreated mycosis fungoides were enrolled into a phase II trial and were treated with temozolomide. The overall response rate was 33%. Further studies are needed to test the efficacy of temozolomide, alone or in combination in earlier stages of this disease.
Figures & Tables
Vol. 90 No. 9 (2005): September, 2005 : Clinical Trial, Phase II
Ferrata Storti Foundation, Pavia, Italy
Statistics from Altmetric.com